Three or One Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus- Eluting Stent Implantation (JACC Cardiovascular Interventions September 2021)

Description

Current generation drug-eluting stents are preferred over bare-metal stents for HBR patients, but their optimal DAPT management remains unknown.

Editors

JACC: Cardiovascular Interventions Editor-in-Chief

David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC/ECME Editor

Michael C. McDaniel, MD

Authors

Roxana Mehran, MD
Davide Cao, MD
Karine Ruster, PhD
Jin Wang, PhD
Marco Valgimigli, MD, PhD

Important Dates

Date of Release: September 6, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: September 5, 2022

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered